Webster Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Webster Bank’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-175	Closed	-$3.86K	–	596
2024 Q4	$3.86K	Hold	175	–	–	﹤0.01%	546
2024 Q3	$3.15K	Hold	175	–	–	﹤0.01%	560
2024 Q2	$2.84K	Hold	175	–	–	﹤0.01%	587
2024 Q1	$2.47K	Hold	175	–	–	﹤0.01%	590
2023 Q4	$1.83K	Hold	175	–	–	﹤0.01%	558
2023 Q3	$1.78K	Hold	175	–	–	﹤0.01%	540
2023 Q2	$1.32K	Hold	175	–	–	﹤0.01%	533
2023 Q1	$1.55K	Hold	175	–	–	﹤0.01%	542
2022 Q4	$2K	Hold	175	–	–	﹤0.01%	522
2022 Q3	$1K	Hold	175	–	–	﹤0.01%	529
2022 Q2	$1K	Hold	175	–	–	﹤0.01%	526
2022 Q1	$2K	Hold	175	–	–	﹤0.01%	528
2021 Q4	$1K	Hold	175	–	–	﹤0.01%	538
2021 Q3	$2K	Hold	175	–	–	﹤0.01%	524
2021 Q2	$2K	Hold	175	–	–	﹤0.01%	509
2021 Q1	$2K	Sell	175 -224	-56%	-$2.57K	﹤0.01%	528
2020 Q4	$4K	Sell	399 -1	-0.3%	-$10	﹤0.01%	501
2020 Q3	$4K	Hold	400	–	–	﹤0.01%	480
2020 Q2	$5K	Hold	400	–	–	﹤0.01%	463
2020 Q1	$4K	Hold	400	–	–	﹤0.01%	467
2019 Q4	$4K	Sell	400 -300	-43%	-$2.68K	﹤0.01%	496
2019 Q3	$5K	Hold	700	–	–	﹤0.01%	477
2019 Q2	$6K	Sell	700 -3,300	-83%	-$39.8K	﹤0.01%	464
2019 Q1	$63K	Sell	4,000 -225	-5%	-$3.97K	0.01%	282
2018 Q4	$65K	Hold	4,225	–	–	0.01%	266
2018 Q3	$91K	Hold	4,225	–	–	0.01%	266
2018 Q2	$103K	Sell	4,225 -1,000	-19%	-$20.4K	0.01%	249
2018 Q1	$89K	Sell	5,225 -8,062	-61%	-$157K	0.01%	276
2017 Q4	$252K	Buy	13,287 +7,700	+138%	+$116K	0.03%	191
2017 Q3	$98K	Sell	5,587 -2,100	-27%	-$47.3K	0.01%	274
2017 Q2	$255K	Sell	7,687 -550	-7%	-$17K	0.04%	188
2017 Q1	$264K	Sell	8,237 -1,349	-14%	-$46K	0.04%	191
2016 Q4	$348K	Buy	9,586 +417	+5%	+$16.6K	0.05%	174
2016 Q3	$422K	Buy	9,169 +531	+6%	+$27.7K	0.06%	158
2016 Q2	$434K	Buy	8,638 +300	+4%	+$16K	0.06%	152
2016 Q1	$446K	Sell	8,338 -217	-3%	-$12.7K	0.07%	153
2015 Q4	$562K	Sell	8,555 -99	-1%	-$6.12K	0.09%	137
2015 Q3	$489K	Buy	8,654 +98	+1%	+$6.35K	0.09%	131
2015 Q2	$506K	Sell	8,556 -225	-3%	-$13.9K	0.08%	135
2015 Q1	$547K	Buy	8,781 +19	+0.2%	+$1.1K	0.09%	132
2014 Q4	$504K	Sell	8,762 -825	-9%	-$46K	0.08%	139
2014 Q3	$515K	Sell	9,587 -275	-3%	-$14.6K	0.09%	130
2014 Q2	$517K	Sell	9,862 -7,250	-42%	-$371K	0.09%	125
2014 Q1	$905K	Buy	17,112 +9,625	+129%	+$445K	0.13%	107
2013 Q4	$300K	Sell	7,487 -12,072	-62%	-$475K	0.04%	172
2013 Q3	$739K	Sell	19,559 -10,163	-34%	-$396K	0.11%	117
2013 Q2	$1.17M	Buy	+29,722	New	+$1.16M	0.15%	112

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Webster Bank's TEVA Position: Q1 2025 in Review

Webster Bank sold out of Teva Pharmaceuticals (TEVA) in Q1 2025, closing a stake of 175 shares — an estimated $3.86K sold.

Webster Bank first reported a position in TEVA in Q2 2013 and held it in 47 quarters. The position peaked at $1.17M in Q2 2013. 560 funds tracked by Wall St. Rank hold TEVA as of Q1 2025.

Webster Bank reported no remaining Teva Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Webster Bank sold 175 Teva Pharmaceuticals shares in Q1 2025, an estimated $3.86K.
Webster Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 47 quarters.
Webster Bank's Teva Pharmaceuticals position peaked at $1.17M in Q2 2013.
560 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2025.

Based on Webster Bank's 13F filing for Q1 2025, filed 4 Apr 2025.